CONGENITAL ADRENAL HYPERPLASIA
Clinical trials for CONGENITAL ADRENAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL ADRENAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for CONGENITAL ADRENAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy could ease rare hormone disorder
Disease control OngoingThis study tests a new gene therapy for adults with classic congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. The treatment delivers a working copy of the CYP21A2 gene using a harmless virus. Researchers aim to see if it is safe and can r…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE1, PHASE2 • Sponsor: Adrenas Therapeutics Inc • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Study on virtual Self-Care training for teens with rare hormone disorder pulled before start
Knowledge-focused TerminatedThis study aimed to see if a virtual education program could help teenagers and young adults with congenital adrenal hyperplasia (CAH) learn to manage their own health care as they move from pediatric to adult doctors. It planned to enroll 16- to 22-year-olds already in a related…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: NA • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC